Radiopharmaceuticals Companies

  • Report ID: 6519
  • Published Date: Apr 18, 2025
  • Report Format: PDF, PPT

Companies Dominating the Radiopharmaceuticals Landscape

    There are both large pharmaceutical enterprises and specialized businesses in this competitive sector. Leading companies set themselves apart via technological innovations, intensive research and development, and calculated alliances. While rising players concentrate on specialty technologies and novel medicines, established companies make use of their resources and worldwide reach. Quality and regulatory compliance are vital, and businesses must adhere to strict requirements. Pricing and customer service tactics can have an impact on competition since businesses want to provide value and top-notch assistance. All things considered, the radiopharmaceuticals market is dynamic, propelled by ongoing innovation and a concentration on upholding strict standards for both product development and customer service.

    Here are some leading players in the radiopharmaceuticals market:

    • PharmaLogic Holdings Corp.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Bayer AG
    • Bracco
    • Cardinal Health Inc.
    • Coquí Radiopharmaceuticals Corp
    • Curium Pharma
    • Eli Lilly and Company
    • General Electric Company
    • IRE EliT
    • Bristol Myers Squibb

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

2025 Radiopharmaceuticals Market is evaluated at USD 8.26 billion.

The global radiopharmaceuticals market size crossed USD 7.64 billion in 2024 and it is set to experience impressive growth, with a CAGR above 10.2%, to exceed USD 27.01 billion by 2037.

North America is anticipated to register USD 13.29 billion by 2037, attributed to a strong healthcare ecosystem, increasing investments in R&D projects, and a high prevalence of chronic illnesses.

The major players in the market include Bayer AG, Bracco, Cardinal Health Inc., Coquí Radiopharmaceuticals Corp, Curium Pharma, Eli Lilly and Company, General Electric Company, IRE EliT, and Bristol Myers Squibb.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

See our insights in action - schedule your demo now!

Live Sample Reading